Operating Lease, Liability, Noncurrent in USD of Spyre Therapeutics, Inc. from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Spyre Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent history and change rate from Q1 2019 to Q4 2023.
  • Spyre Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending 31 Dec 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Change (%)

Spyre Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$4M -100% 31 Dec 2023 10-K/A 18 Nov 2024
Q3 2023 $0 -$4.16M -100% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $0 -$4.32M -100% 30 Jun 2023 10-Q 11 Aug 2023
Q1 2023 $3.82M -$644K -14.4% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $4M -$604K -13.1% 31 Dec 2022 10-K/A 18 Nov 2024
Q3 2022 $4.16M -$587K -12.4% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $4.32M -$564K -11.6% 30 Jun 2022 10-Q 04 Aug 2022
Q1 2022 $4.47M -$542K -10.8% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $4.61M -$521K -10.2% 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $4.75M -$201K -4.06% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $4.88M +$185K +3.94% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $5.01M +$194K +4.03% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $5.13M +$417K +8.85% 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $4.95M +$80K +1.64% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $4.7M -$120K -2.49% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $4.82M +$4.44M +1194% 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $4.71M 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 $4.87M 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $4.82M 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $372K 31 Mar 2019 10-Q 07 May 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.